Ask the expert: Drug codes and epidural steroid injections

Why This Topic Matters

Pain management practices frequently face questions about injectable drug reporting and whether repeat procedures remain supportable after an unsuccessful series. Understanding the general issues covered here can help readers decide whether the full article is relevant to their coding, compliance, and reimbursement workflows.

Article Sections

1. Introduction

   Sets up the source of the questions and identifies the pain management coding context for the discussion.

2. Question: How should we report lidocaine with new code J2003?

   Addresses drug reporting considerations in relation to a newly introduced lidocaine-related code and the surrounding setting-of-care context.

3. Question: If a patient fails the diagnostic series for epidural steroid injections, could that support continuing ESIs?

   Discusses follow-up questions about repeated epidural steroid injections, including broad payer-policy and medical-necessity themes.